Publications & Presentations
Clinical and Economic Considerations in the Use of COX-2 Specific Inhibitors@, Western Branches, Canadian Society of Health-System Pharmacists, 27th Annual Banff Seminar, Calgary, Alberta, Canada, March 17, 2001.
New Drugs of 2000,@ 49th Annual Postgraduate Pharmacy Seminar, The University of Texas at Austin College of Pharmacy, Austin, Texas, September 15, 2001.
Advances in Acid Suppression Therapy@, Annual Installation of Officers, Bexar County Pharmacy Association, San Antonio, Texas, February 8, 2001.
Evaluation of COX-1 and COX-2 Inhibitors@, Department of Defense Pharmacoeconomics/Pharmacy Benefit Conference, San Antonio, Texas, January 8, 2001.
The Pharmacodynamics of Proton Pump Inhibitors@, Houston Gastroenterology Summit, Houston, Texas, October 7, 2000.
Therapeutic Approaches in the Management of GERD: An Update,@ Central Texas Society of Hospital Pharmacists, San Antonio, Texas, August 8, 2000.
Cox-2 Technology: A Year in Review. The Promise and the Potential,@ Longs Drug Stores Pharmacy Managers Meeting 2000, Palm Springs, California, May 25, 2000.
Overview of the Pharmacology and GI Safety and Tolerability of COX-2 Inhibitors, @ Satellite Symposium entitled ACOX-2 Technology: A Year in Review. The Promise and the Potential, @ American Pharmaceutical Association Annual Meeting, Washington, D.C., March 13, 2000.
The Economic Burden of Arthritis and Cost Issues Related to the Use of COX-2 Inhibitors, @ Satellite Symposium entitled ACOX-2 Technology: A Year in Review. The Promise and the Potential, @ American Pharmaceutical Association Annual Meeting, Washington, D.C., March 13, 2000.
Knodel LC. Sexually transmitted diseases. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathophysiologic Approach. 4th edition. New York: Appleton & Lange, 1999.
Editor, Nonprescription Products: Formulations & Features '98-99. A Companion to the Handbook of Nonprescription Drugs (12th edition, 1998). Washington DC: American Pharmaceutical Association, 1998.
Seltzer JK, Kurt TL, Knodel LC, et al. Drug utilization review of sedative/hypnotic agents in Texas Medicaid patients. J Am Pharm Assoc 2000;40:495-9.
Horton PM, Knodel LC. Dietary supplements containing ephedrine: Is a natural high a safe high? Toxic Substance Mechanisms 1998; 17:95-97.
Dugan DJ, Knodel LC. Alcohol and drugs: a potentially dangerous combination. Toxic Substance Mechanisms 1997;16:385-387.
Hatfield CL, Knodel LC, Talbert RL. Olestra: an ideal substitute for dietary fat? Toxic Substance Mechanisms 1997;16:209-11.
Knodel LC. Adverse health consequences of cigarette smoking also include drug interactions. Toxic Substance Mechanisms 1997;16:87-9.
Education & Research Ctr.
College of Pharmacy
The University of Texas
Health Science Center
7703 Floyd Curl Drive - MC 6220
San Antonio, TX
Email Address: pharmacy
Dr. Chris Frei has been appointed as division head for the college's Pharmacotherapy Division which is located on the UT Health Science Center San Antonio campus.